What is LOPJLB’s current signal on BSEM?

LOPJLB’s latest quantitative signal on BioStem Technologies, Inc. (BSEM) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is BSEM in?

BioStem Technologies, Inc. (BSEM) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does BioStem Technologies, Inc. (BSEM) do?

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue w…

Where is BioStem Technologies, Inc. based / listed?

BioStem Technologies, Inc. is based in US, listed on NASDAQ.

BioStem Technologies, Inc. (BSEM)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.76+1.10%Close

SELLCRISIS · day 9

[SCORES & PROFILE]

FUND: 28
VALUE: 13
GROWTH: 73
GARP: 13
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-45.7%

REV YoY-

ROE-76.1%

EPS YoY-

ROA-58.0%

GROSS

114

NET

[VALUATION]

P/E TTM-1.66

P/E FWD-

SECTOR PE20.58

INDUSTRY PE13.91

P/B1.73

P/FCF-

EV/EBITDA-1.87

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E4.43

ALTMAN Z-

CURR RATIO0.98

ND/EBITDA-

BETA0.26

BioStem Technologies, Inc. (BSEM)

Key stats

Prediction markets

FUNDAMENTALS

Company news